| Filed On | Filing |
|---|---|
| 19 Mar 2026 |
Form 4/A: Kronenfeld Mark A., Director
Received 6,163 shares as a grant or award |
| 13 Aug 2024 |
Form 4/A: Bigal Marcelo, Director
Bought 3,400 shares ($40.8K) |
| 15 Apr 2013 |
Form 4/A: Sanderling Venture Partners Vi Lp, 10% owner and 4 others
Received 79,031 shares by exercise ($662K) · Sold 25,560 shares ($663K) · Sold 348,951 shares ($9.72M) |
| 15 Apr 2013 |
Form 4/A: Sanderling Venture Partners Vi Lp, 10% owner and 5 others
Disposed of 98,596 shares (Other Transaction) · Sold 500,000 shares ($9.47M) |
| 11 Jun 2012 |
Form 4/A: Patou Gary, Chief Medical Officer
Granted 40,000 Stock Option (Right to Buy) |
| 17 Feb 2011 |
Form 4/A: Mpm BioVentures Iv Qp Lp, 10% owner and 9 others
Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M) |
| 17 Feb 2011 |
Form 4/A: Evnin Luke, Director
Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M) |
| 17 Feb 2011 |
Form 4/A: Kailian Vaughn M, 10% owner and 1 other
Received 2,200,247 shares by conversion · Bought 535,714 shares ($3.75M) |
Loading...